LH3 Pill — YELLOW OVAL, 15mm — Losartan

No photo available

Imprint	LH3
Colour	YELLOW
Shape	OVAL
Size	15
Strength	LOSARTAN POTASSIUM 100 mg;HYDROCHLOROTHIAZIDE 25 mg
Dosage form	Tablet, Film Coated
Manufacturer	Watson Laboratories, Inc.
NDC	0591-3750
Schedule	—
Availability	—
Ingredients	LOSARTAN POTASSIUM[LOSARTAN];HYDROCHLOROTHIAZIDE[HYDROCHLOROTHIAZIDE]

What does this imprint mean?

The imprint "LH3" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Losartan

Uses and warnings

BOXED WARNING: BOXED WARNING - Fetal Toxicity: "When pregnancy is detected, discontinue losartan potassium tablets as soon as possible." Drugs affecting the renin-angiotensin system cause fetal injury and death, particularly during the second and third trimesters, resulting in oligohydramnios, lung hypoplasia, and skeletal deformations. Additional Warnings: - Symptomatic hypotension may occur in volume-depleted patients; correct conditions before administration or use lower starting doses - Impaired renal function changes reported in susceptible individuals - Hyperkalemia risk, particularly in diabetic patients with renal impairment

Losartan potassium tablets treat hypertension alone or combined with other antihypertensive agents. The medication also addresses diabetic nephropathy with elevated serum creatinine and proteinuria in type 2 diabetes patients with hypertension history, reducing nephropathy progression rates.

Read the full drug profile →